260 related articles for article (PubMed ID: 19349462)
1. Netrin-1 acts as a survival factor for aggressive neuroblastoma.
Delloye-Bourgeois C; Fitamant J; Paradisi A; Cappellen D; Douc-Rasy S; Raquin MA; Stupack D; Nakagawara A; Rousseau R; Combaret V; Puisieux A; Valteau-Couanet D; Bénard J; Bernet A; Mehlen P
J Exp Med; 2009 Apr; 206(4):833-47. PubMed ID: 19349462
[TBL] [Abstract][Full Text] [Related]
2. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer.
Fitamant J; Guenebeaud C; Coissieux MM; Guix C; Treilleux I; Scoazec JY; Bachelot T; Bernet A; Mehlen P
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4850-5. PubMed ID: 18353983
[TBL] [Abstract][Full Text] [Related]
3. Interfering with multimerization of netrin-1 receptors triggers tumor cell death.
Mille F; Llambi F; Guix C; Delloye-Bourgeois C; Guenebeaud C; Castro-Obregon S; Bredesen DE; Thibert C; Mehlen P
Cell Death Differ; 2009 Oct; 16(10):1344-51. PubMed ID: 19543238
[TBL] [Abstract][Full Text] [Related]
4. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
[TBL] [Abstract][Full Text] [Related]
5. Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression.
Paradisi A; Maisse C; Coissieux MM; Gadot N; Lépinasse F; Delloye-Bourgeois C; Delcros JG; Svrcek M; Neufert C; Fléjou JF; Scoazec JY; Mehlen P
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17146-51. PubMed ID: 19721007
[TBL] [Abstract][Full Text] [Related]
6. Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death.
Paradisi A; Creveaux M; Gibert B; Devailly G; Redoulez E; Neves D; Cleyssac E; Treilleux I; Klein C; Niederfellner G; Cassier PA; Bernet A; Mehlen P
EMBO Mol Med; 2013 Dec; 5(12):1821-34. PubMed ID: 24293316
[TBL] [Abstract][Full Text] [Related]
7. The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration.
Villanueva AA; Falcón P; Espinoza N; R LS; Milla LA; Hernandez-SanMiguel E; Torres VA; Sanchez-Gomez P; Palma V
Oncotarget; 2017 Feb; 8(6):9767-9782. PubMed ID: 28038459
[TBL] [Abstract][Full Text] [Related]
8. Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.
Zhu Y; Li Y; Haraguchi S; Yu M; Ohira M; Ozaki T; Nakagawa A; Ushijima T; Isogai E; Koseki H; Nakamura Y; Kong C; Mehlen P; Arakawa H; Nakagawara A
J Clin Invest; 2013 Jul; 123(7):2935-47. PubMed ID: 23778138
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors.
Paradisi A; Maisse C; Bernet A; Coissieux MM; Maccarrone M; Scoazec JY; Mehlen P
Gastroenterology; 2008 Oct; 135(4):1248-57. PubMed ID: 18692059
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.
Bouzas-Rodriguez J; Cabrera JR; Delloye-Bourgeois C; Ichim G; Delcros JG; Raquin MA; Rousseau R; Combaret V; Bénard J; Tauszig-Delamasure S; Mehlen P
J Clin Invest; 2010 Mar; 120(3):850-8. PubMed ID: 20160348
[TBL] [Abstract][Full Text] [Related]
12. Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.
Sahu D; Hsu CL; Lin CC; Yang TW; Hsu WM; Ho SY; Juan HF; Huang HC
Oncotarget; 2016 Sep; 7(36):58022-58037. PubMed ID: 27517149
[TBL] [Abstract][Full Text] [Related]
13. Functional implication of Netrin expression in malignant melanoma.
Kaufmann S; Kuphal S; Schubert T; Bosserhoff AK
Cell Oncol; 2009; 31(6):415-22. PubMed ID: 19940358
[TBL] [Abstract][Full Text] [Related]
14. Netrin-1 acts as a survival factor via its receptors UNC5H and DCC.
Llambi F; Causeret F; Bloch-Gallego E; Mehlen P
EMBO J; 2001 Jun; 20(11):2715-22. PubMed ID: 11387206
[TBL] [Abstract][Full Text] [Related]
15. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Sugimoto T; Gotoh T; Yagyu S; Kuroda H; Iehara T; Hosoi H; Ohta S; Ohira M; Nakagawara A
Cancer Lett; 2013 Apr; 331(1):115-21. PubMed ID: 23268333
[TBL] [Abstract][Full Text] [Related]
16. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
17. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance.
Salm F; Cwiek P; Ghosal A; Lucia Buccarello A; Largey F; Wotzkow C; Höland K; Styp-Rekowska B; Djonov V; Zlobec I; Bodmer N; Gross N; Westermann F; Schäfer SC; Arcaro A
Oncogene; 2013 Aug; 32(34):3944-53. PubMed ID: 23027129
[TBL] [Abstract][Full Text] [Related]
18. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
